Abstract
The invention relates to integrin binding peptides, pharmaceutical compositions comprising the peptides and to uses thereof as therapeutic, diagnostic, imaging and targeting agents.
Original language | English |
---|---|
Patent number | US2018312567 |
IPC | A61P 1/ 16 A I |
Priority date | 21/10/16 |
Publication status | Published - 1 Nov 2018 |